So, Medtronic is shaking things up, especially with their diabetes division. They’re planning to split it off into its own ...
Medtronic (NYSE:MDT) today announced new milestones for its Affera family of technologies, including FDA breakthrough device ...
Medtronic (NYSE:MDT) today announced new clinical findings supporting its Aurora EV-ICD system and OmniaSecure defibrillation ...
The FDA has classified a corrective action for Tandem Diabetes Care’s Mobi insulin pumps as a Class I recall, its highest ...
The U.S. Food and Drug Administration has classified a corrective action involving insulin pumps from Tandem Diabetes Care ...
Sedentary behaviour is associated with an increased risk of cardiovascular disease and all-cause mortality in people with ...
Medtronic launches Adaptive DBS in India, offering real‑time Parkinson’s therapy with BrainSense™ to improve patient quality ...
A malfunction may cause insulin delivery to stop. Tandem instructed users to update their pump software as soon as possible.
Report OverviewThe global insulin pumps market is projected to grow at a rate of 12% by 2028, fueled by rising diabetes ...
As technology becomes more integrated and personalized, experts say the biggest opportunity in diabetes management is ...
New glucose sensors and a partnership with Abbott are expected to drive sales growth at MiniMed, BTIG analyst Marie Thibault ...
The China Diabetes Devices Market is projected to grow from USD 7.19 billion in 2025 to USD 14.51 billion by 2034, marking a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results